How decentralisation can fill the gaps in Alzheimer’s research
In a new era of Alzheimer’s disease research, the emergence of blockbuster therapies like Eli Lilly’s Kisunla (donanemab) and Eisai…
All articles by Irena Maragkou
Irena Maragkou
Irena Maragkou is a Healthcare Researcher for Clinical Trials Arena and Pharmaceutical Technology based in London, UK. Irena previously worked in consulting at Deloitte’s Strategy, M&A and Analytics Department, focusing on projects in the Pharmaceutical and Healthcare Sector. She holds an MSci degree in Neuroscience from UCL.
-
-
Mapping out strategies to overcome challenges in clinical research
In the backdrop of geopolitical disruptions impacting supply chains in many industries, the healthcare and pharma sectors are facing several…
-
Obesity trial surge puts the focus back on decentralisation
The rise of GLP-1 receptor agonists (GLP-1RAs) has ignited a surge in the obesity market in recent years, transforming treatment…
-
CPHI Europe: Targeting supply chain bottlenecks key for cell and gene therapies
Cell therapies stand at the frontier of medicine and hold the potential to potentially cure diseases, said Angela Vollstedt, global…
-
Digital tools offer opportunity to lower clinical trial costs
In a clinical trial, there is a bigger burden of implementing digital tools on the contract research organisation (CRO) than…
-
Gamification could help improve patient retention and engagement in clinical trials
Gamification could be a potential solution to addressing patient engagement and compliance in clinical trials, said Christer Nilsson, CEO of…
-
The course to forging long-term manufacturing partnerships for gene therapies
The current adeno-associated virus (AAV) vector manufacturing landscape in 2024 is a “buyer’s market” with companies competing for clinical trial…
-
Charting the road to operational success in clinical trials
At the upcoming 12th Annual Outsourcing in Clinical Trials & Clinical Trial Supply Nordics meeting, experts from the pharmaceutical, biotechnology…
-
Era of ADCs: Pharma companies innovate to stand out in a buzzing market
Antibody drug conjugates (ADCs) have taken over the cancer clinical research and dealmaking landscape, with new partnerships and agreements being…
-
Will anti-homosexuality bills in sub-Saharan Africa impede HIV research?
As sub-Saharan African countries introduce more anti-homosexuality bills, there are concerns they could create a barrier to the LGBTQI+ community…